Loading...
Loading...
ASPI| Name | Value |
|---|---|
| Revenues | 1,022.3K |
| Cost of Revenue | 601.3K |
| Gross Profit | 421.0K |
| Operating Expense | 7,878.5K |
| Operating I/L | -7,457.5K |
| Other Income/Expense | -1,410.2K |
| Interest Income | 43.5K |
| Pretax | -8,867.7K |
| Income Tax Expense | 13.8K |
| Net Income/Loss | -8,932.9K |
ASP Isotopes Inc. is a pre-commercial stage advanced materials company specializing in the production, distribution, marketing, and sale of isotopes. The company's product portfolio includes Molybdenum-100, a non-radioactive isotope used in the medical industry, Carbon-14, and Silicon-28. Additionally, ASP Isotopes Inc. offers Uranium-235, an isotope of uranium catering to the carbon-free energy industry. By developing and supplying these isotopes, the company generates revenue through their sale to various industries, including medical and energy sectors.
